Viewing Study NCT01513135


Ignite Creation Date: 2025-12-24 @ 10:17 PM
Ignite Modification Date: 2025-12-31 @ 10:15 PM
Study NCT ID: NCT01513135
Status: COMPLETED
Last Update Posted: 2016-03-04
First Post: 2012-01-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers
Sponsor: Barbara Ensoli, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module